Larson Financial Group’s Jazz Pharmaceuticals JAZZ Stock Holding History

Larson Financial Group’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$171K	Buy	709 +281	+66%	+$61.6K	﹤0.01%	911
2026 Q1	$80.9K	Buy	428 +83	+24%	+$14.5K	﹤0.01%	1094
2025 Q4	$58.6K	Buy	345 +40	+13%	+$6.13K	﹤0.01%	1162
2025 Q3	$40.2K	Sell	305 -36	-11%	-$4.32K	﹤0.01%	1251
2025 Q2	$36.2K	Buy	341 +243	+248%	+$26.4K	﹤0.01%	1204
2025 Q1	$12.2K	Buy	98 +36	+58%	+$4.7K	﹤0.01%	1558
2024 Q4	$7.63K	Buy	62 +56	+933%	+$6.6K	﹤0.01%	1565
2024 Q3	$668	Buy	6 +3	+100%	+$329	﹤0.01%	2068
2024 Q2	$320	Hold	3	–	–	﹤0.01%	1948
2024 Q1	$361	Hold	3	–	–	﹤0.01%	1586
2023 Q4	$369	Hold	3	–	–	﹤0.01%	1598
2023 Q3	$388	Hold	3	–	–	﹤0.01%	1598
2023 Q2	$372	Hold	3	–	–	﹤0.01%	1470
2023 Q1	$439	Hold	3	–	–	﹤0.01%	1422
2022 Q4	$478	Hold	3	–	–	﹤0.01%	1371
2022 Q3	$0	Hold	3	–	–	﹤0.01%	1347
2022 Q2	$0	Hold	3	–	–	﹤0.01%	1247
2022 Q1	$0	Hold	3	–	–	﹤0.01%	1111
2021 Q4	$0	Buy	+3	New	+$394	﹤0.01%	1128
2020 Q1	–	Sell	-15	Closed	-$2K	–	595
2019 Q4	$2K	Hold	15	–	–	﹤0.01%	455
2019 Q3	$2K	Hold	15	–	–	﹤0.01%	437
2019 Q2	$2K	Hold	15	–	–	﹤0.01%	389
2019 Q1	$2K	Hold	15	–	–	﹤0.01%	380
2018 Q4	$2K	Buy	+15	New	+$2.23K	﹤0.01%	359

Other funds holding JAZZ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Larson Financial Group's JAZZ Position: Q2 2026 in Review

Larson Financial Group increased its Jazz Pharmaceuticals (JAZZ) stake by 66% in Q2 2026, buying an estimated $61.6K and bringing the position to 709 shares worth $171K. The position accounts for ﹤0.01% of the portfolio, ranked #911.

Larson Financial Group first reported a position in JAZZ in Q4 2018 and has held it in 24 quarters since. 646 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

Larson Financial Group held 709 shares of Jazz Pharmaceuticals worth $171K as of Q2 2026.
Larson Financial Group bought 281 Jazz Pharmaceuticals shares in Q2 2026, an estimated $61.6K.
Jazz Pharmaceuticals made up ﹤0.01% of Larson Financial Group's portfolio in Q2 2026, its #911 holding.
Larson Financial Group first reported a position in Jazz Pharmaceuticals in Q4 2018 and has held it in 24 quarters since.
646 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Larson Financial Group's 13F filing for Q2 2026, filed 14 Aug 2026.